NCT06064955 (Pair 2 Care) is a NA clinical trial of Peer Support in Family Caregiver, sponsored by Ohio State University.

Who is sponsoring NCT06064955?

NCT06064955 is sponsored by Ohio State University.

What drugs are being tested in NCT06064955?

Interventions in NCT06064955: Peer Support.

What condition does NCT06064955 study?

NCT06064955 studies Family Caregiver, Dementia, Peer Support.

Is NCT06064955 still recruiting?

NCT06064955 is currently completed. Last updated 13 February 2025.

Are results published for NCT06064955?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2025-02-13 · How we verify

NCT06064955: Pair 2 Care

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pair 2 Care: Peer Support for Caregivers of Black Americans Living With Dementia

Completed NA Results posted Last updated 13 February 2025

What this trial tests

NA trial testing Peer Support in Family Caregiver in 15 participants. Completed in 11 July 2024.

Timeline

5 October 2023

Primary endpoint
11 July 2024

11 July 2024

Quick facts

Lead sponsor	Ohio State University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	supportive care
Enrollment	15
Start date	5 October 2023
Primary completion	11 July 2024
Estimated completion	11 July 2024
Sites	1 location across United States

Drugs / interventions tested

Peer Support

Conditions studied

Family Caregiver — all drugs for Family Caregiver →
Dementia — all drugs for Dementia →
Peer Support — all drugs for Peer Support →

Sponsor

Ohio State University

Who can join

18 and older, any sex, with Family Caregiver or Dementia. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Medical Outcomes Study Social Support Survey (MOS SSS) Primary · Baseline and 6 months post baseline

This instrument contains 19 items that comprise 4 subscales: Emotional/Informational Support, Tangible Support, Affectionate Support, and Positive Social Interaction. Each item is scored on a 5 point Likert scale of 1 ("none of the time") to 5 ("all the time"), with higher scores indicating more social support. Total and subscale scores are in a range of 1-5 calculated by taking the mean across items.

Emotional/Informational Support at Baseline

Group	Value	95% CI
Peer Support	3.75	± 1.03

Emotional/Informational Support at 6 Months

Group	Value	95% CI
Peer Support	3.79	± 0.99

Tangible support at Baseline

Group	Value	95% CI
Peer Support	3.68	± 1.02

Tangible support at 6 months

Group	Value	95% CI
Peer Support	3.50	± 1.29

Affectionate support at Baseline

Group	Value	95% CI
Peer Support	4.22	± 0.67

Affectionate support at 6 months

Group	Value	95% CI
Peer Support	3.95	± 0.90

Positive social interaction at Baseline

Group	Value	95% CI
Peer Support	4.11	± 0.72

Positive social interaction at 6 months

Group	Value	95% CI
Peer Support	3.98	± 0.83

Sponsor's own description

The purpose of this study is to test a peer support intervention for caregivers who are caring for a loved one living with dementia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A Peer Support Intervention for Black Family Caregivers of Persons Living With Dementia: A Feasibility Study.
Moss KO, Tan A, Brody AA, Bullock K, et al · · 2026 · PMID 41403114 · DOI 10.1111/jgs.70241

Verify or expand the search:

Other trials of Peer Support

Trials testing the same drug.

NCT07213492 — Multimodal Intervention to Support Hospital-to-Community Transition in Bipolar Disorder · NA · recruiting
NCT05075967 — Getting to Zero Among HHI MSM in the American South · NA · enrolling by invitation
NCT05561595 — Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma · NA · recruiting
NCT06704243 — Peer Support Group for Adolescent and Young Adult (AYA) Allogeneic Stem Cell Transplant Recipients · NA · completed
NCT05587348 — PROmoting Diabetes Education and Management Through Peer Support and Team Referral · NA · completed

Other Ohio State University trials

Trials by the same sponsor.

NCT06542458 — Under-Represented Communities Diagnosed With SCD or MCI Through Tele-Cog · not yet recruiting
NCT07217548 — Solving Stigma Through POV Simulation: Enhancing Pharmacist Empathy-based Practices With Sickle Cell Disease Patients · NA · enrolling by invitation
NCT07215221 — Implementation of TBI-RECOVER in Substance Use Treatment · NA · not yet recruiting
NCT07278427 — Reducing Parental Substance Use and Enhancing Family Resilience Among Rural Families Through Ohio START · recruiting
NCT07490444 — Metric-Optimized Spectacle Prescriptions for Children With Down Syndrome · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06064955 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ohio State University
Last refreshed: 13 February 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06064955.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing